Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Fatal hematogenous relapse of mucinous borderline ovarian tumor of intestinal type.

Louis AR, Gupta SK, Gouda C, Gupta G.

Indian J Med Paediatr Oncol. 2013 Apr;34(2):134-5. doi: 10.4103/0971-5851.116222.

2.

Emergence of CA125 immunoreactivity in recurrent or metastatic primary ovarian mucinous neoplasms of the intestinal type.

Miller K, Millar J, McCluggage WG.

Am J Surg Pathol. 2011 Sep;35(9):1331-6. doi: 10.1097/PAS.0b013e3182233fce.

PMID:
21836488
4.

Borderline ovarian tumours: retrospective analysis of twenty-one cases.

Saygili U, Uslu T, Erten O, Doğan E.

Eur J Gynaecol Oncol. 1998;19(2):182-5.

PMID:
9611063
5.
6.

Mucinous tumors of the ovary: a review.

Hart WR.

Int J Gynecol Pathol. 2005 Jan;24(1):4-25. Review.

PMID:
15626914
7.

Carcinosarcoma-like mural nodule in intestinal-type mucinous ovarian of borderline malignancy: a case report.

Chang WC, Sheu BC, Lin MC, Chow SN, Huang SC.

Int J Gynecol Cancer. 2005 May-Jun;15(3):549-53.

PMID:
15882184
8.

Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature.

Ludwick C, Gilks CB, Miller D, Yaziji H, Clement PB.

Int J Gynecol Pathol. 2005 Jul;24(3):205-17. Review.

PMID:
15968194
9.

Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?

Chiesa AG, Deavers MT, Veras E, Silva EG, Gershenson D, Malpica A.

Int J Gynecol Pathol. 2010 Mar;29(2):108-12. doi: 10.1097/PGP.0b013e3181bc2706.

PMID:
20173495
10.

[Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].

Gaggero G, Sola S, Mora M, Fulcheri E.

Pathologica. 2003 Aug;95(4):185-91. Italian.

PMID:
14577202
11.

Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?

Jordan SJ, Green AC, Whiteman DC, Webb PM; Australian Ovarian Cancer Study Group..

Gynecol Oncol. 2007 Nov;107(2):223-30. Epub 2007 Jul 27.

PMID:
17662378
12.
13.

Histochemical study of mucinous ovarian cystomas of intestinal and mixed types: O-acetylated sialomucin content in relation to biologic behavior.

Fulcheri E, Baracchini P, Foglia G, Lapertosa G, Siciliano B, Ragni N.

Tumori. 1990 Feb 28;76(1):73-6.

PMID:
2321278
14.

Ovarian epithelial tumors of borderline malignancy in Japan.

Nakashima N, Nagasaka T, Oiwa N, Nara Y, Fukata S, Fukatsu T, Takeuchi J.

Gynecol Oncol. 1990 Jul;38(1):90-8.

PMID:
2162318
15.
16.

Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.

Baker PM, Oliva E, Young RH, Talerman A, Scully RE.

Am J Surg Pathol. 2001 May;25(5):557-68.

PMID:
11342766
17.

Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.

McCluggage WG, Young RH.

Semin Diagn Pathol. 2005 Feb;22(1):3-32. Review.

PMID:
16512597
19.

Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.

Kelly PJ, Archbold P, Price JH, Cardwell C, McCluggage WG.

J Clin Pathol. 2010 Feb;63(2):169-73. doi: 10.1136/jcp.2009.072355.

PMID:
20154039
20.

Safety of simple cystectomy in patients with unilateral mucinous borderline tumors.

Salomon LJ, Lhommé C, Pautier P, Duvillard P, Morice P.

Fertil Steril. 2006 May;85(5):1510.e1-4.

PMID:
16647380

Supplemental Content

Support Center